Neuromyotonia: Remembering a Rare Pathology

Authors

DOI:

https://doi.org/10.24950/CC/71/20/3/2020

Keywords:

Isaacs Syndrome/diagnosis, Isaacs Syndrome /therapy

Abstract

Neuromyotonia is an exceedingly rare disease. In most cases it seems to be acquired, with a probable autoimmune origin. It is characterized by peripheral nerve hyperexcitability with muscle hyperactivity and deficient relaxation, and it is frequently accompanied by autonomic and sensitive symptoms. The diagnosis is established by electromyography, showing spontaneous, multiple single motor unit discharges, firing at a high frequency. The diagnosis is relevant not only to achieve symptom control but also for its known association with neoplasia, which must be ruled out. Nevertheless, the diagnosis is difficult to establish due to the nonspecific and variable symptoms that may lead to confusion with the more common psychiatric or motor neuron diseases. Misdiagnose can result in incorrect therapeutic actions with further iatrogenic symptoms. We report a typical case of neuromyotonia, in respect of which we review the clinical presentation, complementary diagnostic methods, natural evolution and treatment of the disease.

Downloads

Download data is not yet available.

References

Maddison P. Neuromyotonia. Pract Neurol. 2002;2:225-9.doi:10.1046/j.1474-7766.2002.00068.x

Ahmed A, Simmons Z. Isaacs syndrome: A review. Muscle Nerve. 2015;52:5-12. doi:10.1002/mus.24632

Sawlani K, Katirji B. Peripheral nerve hyperexcitability syndromes. Continuum. 2017;23:1437–50. doi: 10.1212/CON.0000000000000520

Orpha.net [homepage na Internet]. Paris: Instituto Nacional Francês para a Saúde e Investigação Médica. [consultado 10 Abril 2020] Disponível em: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=84142

Lee W, Day TJ, Williams DR.Clinical, laboratory and electrophysiological features of Morvan’s Fibrillary Chorea. J Clin Neurosci. 2013;20:1246–9. doi:10.1016/j.jocn.2012.10.029

Hart IK, Maddison P, Newsome-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125:1887–95. doi:10.1093/brain/awf178

Vincent A., Pettingill P., Pettingill R., Lang B., Birch R.,Waters P, et al. Association of leucine-rich glioma inactivated protein 1, contactin associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia. JAMA Neurol. 2018;75:1519–27. doi:

1001/jamaneurol.2018.2681

Nakatsuji Y, Kaido M, Sugai F, Nakamori M, Abe K, Watanabe O, Arimura K, Sakoda S. Isaacs' syndrome successfully treated by immunoadsorption plasmapheresis. Acta Neurol Scand. 2000;102:271-3. doi: 10.1034/j.1600--0404.2000.102004271.x.

Béquet D, Devière F, Renard JL, Felten D. Syndrome d'Isaacs: amélioration durable par les immunoglobulines polyvalentes intraveineuses. Rev Neurol. 1997;153:602-4.

Published

2021-09-30

How to Cite

1.
Martins SR, Xavier Pires S, Marinho A. Neuromyotonia: Remembering a Rare Pathology. RPMI [Internet]. 2021 Sep. 30 [cited 2024 Dec. 18];27(3):245-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/124

Issue

Section

Case Reports

Most read articles by the same author(s)